Reply to Letter to the Editor on Mease et al.
Publication Title
Arthritis Rheumatol
Document Type
Article
Publication Date
4-7-2020
Abstract
We read with interest the Letter to the Editor by Kerschbaumer et al regarding our article on the primary results from the SEAM-PsA trial (1). We appreciated the comments highlighting the methotrexate (MTX) monotherapy results. Since MTX is a drug that has been long used in psoriatic arthritis (PsA) without much data from rigorous and well-controlled clinical trials, we sought to provide reliable data about MTX through SEAM-PsA.
Clinical Institute
Orthopedics & Sports Medicine
Specialty
Rheumatology